Clinical Trial Abundance, Made in China

A guest post by Jacob Stern:I work with Sid Sijbrandij, a technology entrepreneur who has taken a radically personalized and high-agency approach to fighting his osteosarcoma (bone cancer). Before meeting Sid, I was a product lead at 10x Genomics, a sequencing technology company developing novel tools for understanding biology. Sid was the first person I met who had used 10x tools to inform their care. I now run the enterprise of Sid’s care, pursuing a strategy of maximal diagnostics, making per...